{"name":"iTeos Belgium SA","slug":"iteos-belgium-sa","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNeWNxS292cFJ2U3NZUi1LMTVNblNDYm9yMkdsc1JJYzNWOWwwX1BhNlYwcFBReXNLRC1STk96RTdxUjJrLVQyRFZzSktrdGVBbFVqQVRWcm1lVnJQN3VCUk5UZEFTY3lBYW5lZnlNX3RUTWI3Y0NHR1dtWGY3Tld0am8wVjBiUmpwb2FPcUZjWHNiVHBhOTV6TXVUYkdKTkhidlpMWnNyUQ?oc=5","date":"2025-07-21","type":"deal","source":"fiercebiotech.com","summary":"iTeos, reeling from TIGIT fail, becomes latest prize for deal-hungry Concentra - fiercebiotech.com","headline":"iTeos, reeling from TIGIT fail, becomes latest prize for deal-hungry Concentra","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxPaktiMXBXVlVwOXM0NllET1VDRlR1T1JpeGdGUnMteEtKcTE4RVhFelppVkVycWxyTmxSLXlFQjlvQjJjNFJyeWE3NHB1eFJDWGI3QnBQVURsdEV2QmEyRUlNNDJ5a3MwdURDWlhic2FqZU1VZDd4OGdMVEFqSDUyZ0xUd0E3N1N3S0taMXJyOHV5VW5sRG5QUkRyWmxKQQ?oc=5","date":"2025-05-28","type":"pipeline","source":"fiercebiotech.com","summary":"Adios, iTeos: Biotech folds weeks after GSK TIGIT termination - fiercebiotech.com","headline":"Adios, iTeos: Biotech folds weeks after GSK TIGIT termination","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}